Qiagen NV (XTER:QIA) 3-Year FCF Growth Rate

: 25.20% (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

Qiagen NV's Free Cash Flow per Share for the three months ended in Dec. 2023 was €0.41.

During the past 12 months, Qiagen NV's average Free Cash Flow per Share Growth Rate was -47.70% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 25.20% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 32.20% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 8.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Qiagen NV was 115.30% per year. The lowest was -38.00% per year. And the median was 3.10% per year.

Competitive Comparison

For the Diagnostics & Research subindustry, Qiagen NV's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qiagen NV 3-Year FCF Growth Rate Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Qiagen NV's 3-Year FCF Growth Rate falls into.

Qiagen NV 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

Qiagen NV (XTER:QIA) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.

Qiagen NV 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Qiagen NV's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV (XTER:QIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (XTER:QIA) » Definitions » 3-Year FCF Growth Rate

Comparable Companies

Traded in Other Exchanges

QGEN:USA 1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QIA:Germany QIA:Germany QGEN:Austria

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Qiagen NV (XTER:QIA) Headlines

No Headlines